15.54% to Target, Citigroup Keeps “Buy” Rating for South32 Limited (LON:S32) Stock; Holland Capital Management Trimmed Biogen (BIIB) Position By $854,192

December 7, 2017 - By Peter Erickson

Holland Capital Management Llc decreased Biogen (BIIB) stake by 4.34% reported in 2017Q2 SEC filing. Holland Capital Management Llc sold 3,152 shares as Biogen (BIIB)’s stock declined 13.45%. The Holland Capital Management Llc holds 69,449 shares with $18.85 million value, down from 72,601 last quarter. Biogen now has $66.54B valuation. The stock decreased 1.63% or $5.21 during the last trading session, reaching $314.66. About 938,762 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since December 7, 2016 and is uptrending. It has underperformed by 11.76% the S&P500.

South32 Limited (LON:S32) had its stock rating noted as “Buy” by analysts at Citigroup. Citigroup currently has a GBX 210.00 price target on the 10.30B GBP market cap company or 15.54% upside potential. This was disclosed in a research note on 6 December.

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on January, 25. They expect $5.55 EPS, up 10.12% or $0.51 from last year’s $5.04 per share. BIIB’s profit will be $1.17B for 14.17 P/E if the $5.55 EPS becomes a reality. After $6.31 actual EPS reported by Biogen Inc. for the previous quarter, Wall Street now forecasts -12.04% negative EPS growth.

Among 31 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 21 have Buy rating, 0 Sell and 10 Hold. Therefore 68% are positive. Biogen Idec Inc. has $450 highest and $268 lowest target. $349.72’s average target is 11.14% above currents $314.66 stock price. Biogen Idec Inc. had 92 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, July 27. The stock has “Market Perform” rating by Raymond James on Thursday, September 21. The firm earned “Hold” rating on Wednesday, October 4 by RBC Capital Markets. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Market Perform” rating by BMO Capital Markets on Friday, July 24. As per Friday, August 25, the company rating was maintained by Robert W. Baird. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Market Perform” rating by BMO Capital Markets on Wednesday, September 13. As per Friday, July 14, the company rating was maintained by Nomura. The rating was maintained by Stifel Nicolaus with “Hold” on Friday, December 9. Bernstein initiated the stock with “Outperform” rating in Wednesday, June 29 report. The firm has “Neutral” rating by Citigroup given on Monday, October 23.

Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.16, from 1.04 in 2017Q1. It fall, as 81 investors sold BIIB shares while 321 reduced holdings. 78 funds opened positions while 277 raised stakes. 180.66 million shares or 1.01% less from 182.50 million shares in 2017Q1 were reported. Clarivest Asset Mgmt, California-based fund reported 60,462 shares. Fortaleza Asset Mngmt holds 2,630 shares or 1.36% of its portfolio. Guardian Life Insur Of America reported 484 shares stake. Arvest Fincl Bank Division invested 0.93% of its portfolio in Biogen Inc. (NASDAQ:BIIB). California State Teachers Retirement Sys holds 0.23% in Biogen Inc. (NASDAQ:BIIB) or 392,134 shares. Alpha Windward owns 51 shares or 0.01% of their US portfolio. Buckingham Cap holds 0.15% or 2,405 shares. 6,655 are held by Nine Masts Capital Ltd. Aviance Prtnrs Limited Liability Company holds 0.38% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 4,376 shares. 770 were accumulated by Ssi Inv Management Inc. Symphony Asset Mngmt Ltd Limited Liability Company accumulated 11,045 shares or 0.34% of the stock. Sky Inv Limited Liability Company owns 1,151 shares for 0.13% of their portfolio. Cullen Frost Bankers invested in 16,048 shares. British Columbia Mgmt Corporation holds 0.27% or 122,955 shares in its portfolio. Burney Company holds 0.19% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 10,805 shares.

The stock decreased 0.55% or GBX 1 during the last trading session, reaching GBX 180.75. About 239,248 shares traded. South32 Limited (LON:S32) has 0.00% since December 7, 2016 and is . It has underperformed by 16.70% the S&P500.

South32 Limited operates as a diversified metals and mining firm primarily in Australia, Southern Africa, and South America. The company has market cap of 10.30 billion GBP. The firm has a portfolio of assets producing alumina, aluminum, bauxite, energy and metallurgical coal, manganese ore and alloy, ferronickel, silver, lead, and zinc. It has a 7.89 P/E ratio. It also exports its products.

Among 12 analysts covering South32 Limited Ord Npv Di Wi (LON:S32), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. South32 Limited Ord Npv Di Wi has GBX 240 highest and GBX 47 lowest target. GBX 176.42’s average target is -2.40% below currents GBX 180.75 stock price. South32 Limited Ord Npv Di Wi had 202 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Friday, June 2 by Macquarie Research. On Monday, September 14 the stock rating was maintained by Jefferies with “Hold”. The company was maintained on Monday, February 13 by Macquarie Research. The firm has “Buy” rating by Deutsche Bank given on Wednesday, February 3. As per Thursday, November 10, the company rating was maintained by Macquarie Research. The stock has “Overweight” rating by Barclays Capital on Wednesday, November 2. The company was maintained on Wednesday, March 30 by Jefferies. The firm earned “Buy” rating on Friday, October 23 by Deutsche Bank. Liberum Capital maintained South32 Limited (LON:S32) on Monday, August 24 with “Hold” rating. The stock of South32 Limited (LON:S32) has “Hold” rating given on Friday, August 26 by Deutsche Bank.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: